Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > CEO bought 100k - just filed

<< Previous

Bullboard Posts

Next >>

Comment by sakinny3on Oct 02, 2021 3:07am

182 Views

Post# 33957058

RE:RE:RE:CEO bought 100k - just filed

lscfa wrote:
It is a interesting development, because if he has bought in the market rather than put 20,000 cash into the company coffers by exercising it would suggest there is no immediate need of cash injection. He probably exercised expiring warrants and it has been reported wrong as open market purchase.

lscfa wrote: I hope you're wrong. If an insider is buying there is no material news imminent.

biorun wrote: Ok, shot from the bow. That is a strong signal.